Latest Phenols Stories
All Items on the Proxy Received Shareholder Approval NEW YORK, Dec. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
DALLAS, December 12, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Opioids Market Overview to 2023 - Opioids in Emerging Markets" industry research report with latest
CORALVILLE, Iowa, Dec.
First-in-class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to laxatives SAN FRANCISCO, Dec.
Lightlake Therapeutics advances collaboration with NIDA for novel intranasal naloxone application to reverse opioid overdose LONDON, Dec.
Pain Insights, Inc.
MarketReportsOnline.com adds "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" report to its research store. Dallas,
Novel Product Virtually Devoid of Opioid Activity Being Studied in Neuropathic Pain. NEW YORK, Dec. 2, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
SAINT LOUIS, Dec.
More Images (1 images) »